Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds
Rainer Hoenig Foundation

Rainer Hoenig Foundation

Donation account

Sparkasse Heidelberg
IBAN: DE98 6725 0020 0005 0000 50
BIC (SWIFT): SOLADES1HDB

In 2020 Hedvig Hoenig, née Schmidt, established the charitable Rainer Hoenig Foundation in memory of her husband, who died in 2018 due to bile duct carcinoma. She endowed the new foundation without legal capacity with a capital of half a million euros, assigned to the German Cancer Research Center in Heidelberg as the managing trustee.

By establishing their foundation, Mr. and Mrs. Hoenig wanted to support research into bile duct cancer, which to this day is incurable, and to contribute to increasing the chances of those suffering from it, through improved early detection and new therapies. Bile duct carcinoma has been increasing rapidly in recent years in connection with non-viral hepatitis caused by fatty liver, a chronic liver disease. Presently, most patients will die of the disease within five years after being diagnosed. The available therapies can only buy time for the patients, but not cure the disease.

You contact person

Elisabeth Hohensee

Office of Development
German Cancer Research Center
Phone: +49 6221 42-2848
E-mail: spende@dkfz.de

The purpose of the Rainer Hoenig Foundation is the promotion of science and research in the field of bile duct cancer (cholangiocellular carcinoma). Over the next few years, the foundation will finance a research project at the German Cancer Research Center in the division of  "Chronic Inflammation and Cancer". Among other things, the funded research project will investigate the molecular and cellular mechanisms of tumor genesis, metastasis and relapse, as well as new immune therapeutic approaches. "My late husband and I unfortunately had to experience during his illness that cancer medicine had reached its limits and could not help him, despite the best efforts of the doctors treating him. That's why we decided to establish a foundation to benefit cancer research, to gain new insights that will further develop and improve treatment options for bile duct cancer ," Hedvig Hoenig explains.

to top
powered by webEdition CMS